- Home
- HNI vs APGE Comparison
HNI vs APGE Comparison
Compare HNI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNI
- APGE
- Stock Information
- Founded
- HNI 1944
- APGE 2022
- Country
- HNI United States
- APGE United States
- Employees
- HNI N/A
- APGE N/A
- Industry
- HNI Office Equipment/Supplies/Services
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HNI Consumer Discretionary
- APGE Health Care
- Exchange
- HNI Nasdaq
- APGE Nasdaq
- Market Cap
- HNI 2.1B
- APGE 1.8B
- IPO Year
- HNI N/A
- APGE 2023
- Fundamental
- Price
- HNI $44.86
- APGE $39.29
- Analyst Decision
- HNI Strong Buy
- APGE Strong Buy
- Analyst Count
- HNI 1
- APGE 4
- Target Price
- HNI $63.00
- APGE $91.33
- AVG Volume (30 Days)
- HNI 486.9K
- APGE 794.7K
- Earning Date
- HNI 04-28-2025
- APGE 03-03-2025
- Dividend Yield
- HNI 2.91%
- APGE N/A
- EPS Growth
- HNI 164.22
- APGE N/A
- EPS
- HNI 2.88
- APGE N/A
- Revenue
- HNI $2,526,400,000.00
- APGE N/A
- Revenue This Year
- HNI $3.51
- APGE N/A
- Revenue Next Year
- HNI $3.75
- APGE $795.25
- P/E Ratio
- HNI $15.73
- APGE N/A
- Revenue Growth
- HNI 3.80
- APGE N/A
- 52 Week Low
- HNI $40.94
- APGE $29.10
- 52 Week High
- HNI $58.42
- APGE $69.40
- Technical
- Relative Strength Index (RSI)
- HNI 50.79
- APGE 51.32
- Support Level
- HNI $42.67
- APGE $38.18
- Resistance Level
- HNI $45.71
- APGE $41.07
- Average True Range (ATR)
- HNI 0.89
- APGE 2.29
- MACD
- HNI 0.36
- APGE 0.15
- Stochastic Oscillator
- HNI 89.80
- APGE 45.24
About HNI HNI Corporation
HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.